StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of BLPH stock opened at $0.05 on Monday. The stock’s fifty day moving average is $0.05 and its 200-day moving average is $0.06. The stock has a market capitalization of $624,953.00, a PE ratio of -0.06 and a beta of 0.67. Bellerophon Therapeutics has a 52 week low of $0.03 and a 52 week high of $11.15.
About Bellerophon Therapeutics
Read More
- Five stocks we like better than Bellerophon Therapeutics
- Ride Out The Recession With These Dividend Kings
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- How is Compound Interest Calculated?
- Merger or Not, Albertson’s Companies is a Good Buy
- What is an Earnings Surprise?
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.